Effect of a single oral dose of methanol, ethanol and propan-2-ol on the hepatic microsomal metabolism of foreign compounds in the rat.
Methanol and ethanol administered to rats as a single oral dose increased aniline hydroxylation by the hepatic microsomal fraction by a maximum of 169 and 66% respectively, whereas aminopyrine demethylation was inhibited by 51 and 61%. The concentration of microsomal cytochrome P-450, and the activities of NADPH-cytochrome c reductase and NADPH-cytochrome P-450 reductase were unchanged. Propan-2-ol, administered as a single oral dose, increased microsomal aniline hydroxylation by 165% and increased aminopyrine demethylation by 83%. The concentration of cytochrome P-450 was unchanged whereas NADPH-cytochrome c reductase and NADPH-cytochrome P-450 reductase were both increased by 38%. Methanol, ethanol and propan-2-ol administration resulted in a decreased type I spectral change but had no effect on the reverse type I spectral change. Methanol administration decreased the type II spectral change whereas ethanol and propan-2-ol had no effect. Cycloheximide blocked the increases in aniline hydroxylation and aminopyrine demethylation but could not completely prevent the decreases in aminopyrine demethylation. The increases in aniline hydroxylation were due to an increase in V, but Km was unchanged. The ability of acetone to enhance and compound SKF 525A to inhibit microsomal aniline hydroxylation was decreased by the administration of all three alcohols. The decrease in the metabolism of aminopyrine may result from a decrease in the binding to the type I site with a consequent failure of aminopyrine to stimulate the reduction of cytochrome P-450. Methanol administration may lead to an increase in aniline hydroxylation because of a failure of aniline to inhibit cytochrome P-450 reduction.
D000433:1-Propanol / Q000008:administration & dosage / Q000494:pharmacology*; D000096:Acetone / Q000494:pharmacology; D000284:Administration, Oral; D000632:Aminopyrine / Q000378:metabolism; D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D003513:Cycloheximide / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System; D003579:Cytochrome Reductases; D003576:Electron Transport Complex IV; D000431:Ethanol / Q000008:administration & dosage / Q000494:pharmacology*; D006900:Hydroxylation; D008297:Male; D000432:Methanol / Q000008:administration & dosage / Q000494:pharmacology*; D008745:Methylation; D008862:Microsomes, Liver / Q000187:drug effects* / Q000378:metabolism; D011335:Proadifen / Q000494:pharmacology; D051381:Rats
D000814:Aniline Compounds; D000632:Aminopyrine; D000096:Acetone; D000431:Ethanol; D003577:Cytochrome P-450 Enzyme System; D000433:1-Propanol; D003513:Cycloheximide; D011335:Proadifen; D003579:Cytochrome Reductases; D003576:Electron Transport Complex IV; D000432:Methanol